ArticleTherapeutic advances in medical oncology2022

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.

Kuo-Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.